# A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

> **NCT00145795** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 20 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Kaletra + Current Dual NRTI Backbone
- **DRUG:** Current Regimen

## Key facts

- **NCT ID:** NCT00145795
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2009-06
- **Final completion:** 2009-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145795, "A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00145795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*